HealthEquity Company Profile (NASDAQ:HQY)

About HealthEquity (NASDAQ:HQY)

HealthEquity logoHealthEquity, Inc. provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions. Its platform provides an ecosystem where consumers can access their tax-advantaged healthcare savings, compare treatment options and pricing, evaluate and pay healthcare bills, receive personalized benefit and clinical information, earn wellness incentives and make educated investment choices to help in their tax-advantaged healthcare savings. Its products and services include healthcare saving and spending platform, health savings accounts, investment advisory services, reimbursement arrangements and healthcare incentives. Its ecosystem primarily consists of HSA.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Software & Technology Services
  • Sub-Industry: N/A
  • Symbol: NASDAQ:HQY
  • CUSIP: N/A
  • Web:
  • Market Cap: $2.96 billion
  • Outstanding Shares: 59,973,000
Average Prices:
  • 50 Day Moving Avg: $50.40
  • 200 Day Moving Avg: $46.06
  • 52 Week Range: $27.45 - $54.95
  • Trailing P/E Ratio: 91.56
  • Foreward P/E Ratio: 70.50
  • P/E Growth: 2.53
Sales & Book Value:
  • Annual Revenue: $189.78 million
  • Price / Sales: 15.60
  • Book Value: $4.86 per share
  • Price / Book: 10.15
  • EBIDTA: $57.61 million
  • Net Margins: 17.04%
  • Return on Equity: 11.61%
  • Return on Assets: 11.06%
  • Current Ratio: 21.28%
  • Quick Ratio: 21.23%
  • Average Volume: 501,427 shs.
  • Beta: 1.78
  • Short Ratio: 6.58
Frequently Asked Questions for HealthEquity (NASDAQ:HQY)

What is HealthEquity's stock symbol?

HealthEquity trades on the NASDAQ under the ticker symbol "HQY."

How were HealthEquity's earnings last quarter?

HealthEquity, Inc. (NASDAQ:HQY) issued its earnings results on Tuesday, June, 6th. The company reported $0.19 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $0.16 by $0.03. The firm had revenue of $55.40 million for the quarter, compared to analyst estimates of $54.77 million. HealthEquity had a return on equity of 11.61% and a net margin of 17.04%. The business's revenue was up 25.9% on a year-over-year basis. During the same period in the previous year, the company posted $0.15 earnings per share. View HealthEquity's Earnings History.

Where is HealthEquity's stock going? Where will HealthEquity's stock price be in 2017?

12 brokers have issued 1 year price targets for HealthEquity's stock. Their predictions range from $35.00 to $61.00. On average, they expect HealthEquity's share price to reach $49.75 in the next year. View Analyst Ratings for HealthEquity.

What are analysts saying about HealthEquity stock?

Here are some recent quotes from research analysts about HealthEquity stock:

  • 1. According to Zacks Investment Research, "HealthEquity, Inc. is a technology-enabled services platforms that empower consumers to make healthcare saving and spending decisions. The Company's platform provides an ecosystem where consumers can access their tax-advantaged healthcare savings, compare treatment options and pricing, evaluate and pay healthcare bills, receive personalized benefit and clinical information, earn wellness incentives, and make educated investment choices to grow their tax-advantaged healthcare savings. HealthEquity, Inc. is headquartered in Draper, Utah. " (7/12/2017)
  • 2. Cantor Fitzgerald analysts commented, "HSA market growth is likely to continue. Industry research indicates that there were 20 million HSAs in place at the end of 2016 with about $37 billion in assets. Given the increased popularity of high deductible health plans, the Devenir HSA report estimates that total HSA assets will increase to $52 billion in 2018. We view HQY as a cross over company as it straddles both the healthcare IT and managed care sectors. The company sells its cloud-based healthcare and spending platform to health plans and employers who offer HSA to members and employees. Generally speaking, we view HSA administration as an attractive niche within the broader benefit administration market. Direct competitors in the HSA market include Optum Bank (owned by UnitedHeatlhGroup, UNH) and Webster Financial (WBS). Benefit administration solution companies include Wageworks (WAGE) and Benefitfocus (BNFT). Consumer/employee engagement represents another niche with the broader market." (3/30/2017)
  • 3. Chardan Capital analysts commented, "Tuesday after market close HealthEquity released F4Q17 earnings with a 12% beat on adj. EBITDA driven by strong performance in their Custodial and Interchange lines of business. The company also guided to 79.5m in adj. EBITDA in F2018E, 1% above Street Consensus. We liked Management's commitment to strong financial performance and their confidence in the demand they see for HSAs in the market during their ongoing selling season. We raise our PT to $53 (from $50) based on the company's higher multiple and reiterate our Buy rating." (3/22/2017)
  • 4. FIX analysts commented, "HealthEquity, as a pure play provider of tax-advantaged health accounts and related services, is perfectly positioned to take advantage of favorable regulatory changes and the increasing shift of healthcare costs toward consumers. Among the various ACA repeal & replace proposals in DC, the one constant appears to be the push to provide ownership to consumers along with first-dollar responsibility through tax-advantaged accounts such as HSAs. A large number of employers have already embarked on this path, and the regulatory shift could significantly speed up this change and drive faster adoption. While HQY shares have moved up post-election in anticipation of favorable changes in consumer-directed health accounts, we believe there is still upside to growth and valuation. Initiate with Outperform, $58 target." (3/14/2017)

Who are some of HealthEquity's key competitors?

Who are HealthEquity's key executives?

HealthEquity's management team includes the folowing people:

  • Robert W. Selander, Independent Chairman of the Board
  • Jon Kessler, President, Chief Executive Officer, Director
  • Stephen D. Neeleman M.D., Vice Chairman of the Board, Founder
  • Darcy G. Mott, Chief Financial Officer, Executive Vice President
  • Ashley Dreier, Executive Vice President, Chief Technology Officer and Chief Information Officer
  • Gary Robinson, Executive Vice President, Chief Marketing Officer
  • Delano W. Ladd, Executive Vice President, General Counsel and Corporate Secretary
  • William Otten, Executive Vice President of Sales
  • Jonathan Soldan, Executive Vice President - Operations
  • Frank A. Corvino, Independent Director

Who owns HealthEquity stock?

HealthEquity's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Peregrine Capital Management LLC (1.11%), Bank of Montreal Can (0.15%), Russell Investments Group Ltd. (0.05%), Louisiana State Employees Retirement System (0.03%), Aperio Group LLC (0.02%) and Anderson Hoagland & Co. (0.02%). Company insiders that own HealthEquity stock include Adrian T Dillon, Ashley Dreier, Berkley Capital, Llc, Darcy G Mott, Delano Ladd, Frank Corvino, Frank Medici, Ian Sacks, Jon Kessler, Jon Soldan, Manu S Rana, Matthew Sydney, Michael O Leavitt and Stephen Neeleman. View Institutional Ownership Trends for HealthEquity.

Who sold HealthEquity stock? Who is selling HealthEquity stock?

HealthEquity's stock was sold by a variety of institutional investors in the last quarter, including Peregrine Capital Management LLC, Anderson Hoagland & Co., Bank of Montreal Can, New England Research & Management Inc. and Capstone Asset Management Co.. Company insiders that have sold HealthEquity stock in the last year include Ashley Dreier, Berkley Capital, Llc, Darcy G Mott, Delano Ladd, Frank Corvino, Frank Medici, Jon Kessler, Jon Soldan, Manu S Rana, Matthew Sydney and Stephen Neeleman. View Insider Buying and Selling for HealthEquity.

Who bought HealthEquity stock? Who is buying HealthEquity stock?

HealthEquity's stock was acquired by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd., Narus Financial Partners LLC, State of Alaska Department of Revenue, Aperio Group LLC, Exane Derivatives, Creative Planning and Louisiana State Employees Retirement System. View Insider Buying and Selling for HealthEquity.

How do I buy HealthEquity stock?

Shares of HealthEquity can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is HealthEquity's stock price today?

One share of HealthEquity stock can currently be purchased for approximately $49.35.

MarketBeat Community Rating for HealthEquity (NASDAQ HQY)
Community Ranking:  3.2 out of 5 (  )
Outperform Votes:  161 (Vote Outperform)
Underperform Votes:  92 (Vote Underperform)
Total Votes:  253
MarketBeat's community ratings are surveys of what our community members think about HealthEquity and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for HealthEquity (NASDAQ:HQY) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Hold Rating, 11 Buy Ratings
Consensus Rating:Buy (Score: 2.92)
Consensus Price Target: $49.75 (0.81% upside)

Analysts' Ratings History for HealthEquity (NASDAQ:HQY)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
7/5/2017Cantor FitzgeraldBoost Price TargetOverweight$55.00 -> $56.00MediumView Rating Details
6/12/2017Oppenheimer Holdings, Inc.Reiterated RatingOutperform$57.00 -> $61.00LowView Rating Details
6/7/2017Chardan CapitalBoost Price TargetBuy -> Buy$53.00 -> $57.00HighView Rating Details
3/22/2017J P Morgan Chase & CoBoost Price TargetOverweight$44.00 -> $51.00HighView Rating Details
3/14/2017CIBCInitiated CoverageOutperform -> OutperformMediumView Rating Details
3/14/2017FIXInitiated CoverageOutperformMediumView Rating Details
3/14/2017Wells Fargo & CompanyInitiated CoverageOutperformMediumView Rating Details
1/23/2017KeyCorpInitiated CoverageOverweight$60.00N/AView Rating Details
9/12/2016Raymond James Financial, Inc.Boost Price TargetOutperform$32.00 -> $40.00N/AView Rating Details
9/8/2016SunTrust Banks, Inc.Reiterated RatingBuyN/AView Rating Details
9/8/2016Barrington ResearchBoost Price TargetOutperform$34.00 -> $38.00N/AView Rating Details
9/7/2016Robert W. BairdBoost Price TargetNeutral$31.00 -> $35.00N/AView Rating Details
6/8/2016Leerink SwannReiterated RatingOutperform$30.00 -> $33.00N/AView Rating Details
3/23/2016Avondale PartnersBoost Price TargetMarket Outperform$25.00 -> $27.00N/AView Rating Details
(Data available from 7/25/2015 forward)


Earnings History for HealthEquity (NASDAQ:HQY)
Earnings by Quarter for HealthEquity (NASDAQ:HQY)
Earnings History by Quarter for HealthEquity (NASDAQ HQY)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
6/6/2017Q1 2018$0.16$0.19$54.77 million$55.40 millionViewListenView Earnings Details
3/21/2017Q4 2017$0.05$0.07$45.55 million$46.83 millionViewN/AView Earnings Details
12/6/2016Q3 2017$0.09$0.10$43.29 million$43.36 millionViewN/AView Earnings Details
9/6/2016Q2$0.13$0.16$43.28 million$44.19 millionViewN/AView Earnings Details
6/7/2016Q1$0.13$0.15$42.06 million$44.01 millionViewN/AView Earnings Details
3/22/2016Q4$0.04$0.07$34.90 million$35.89 millionViewListenView Earnings Details
12/7/2015Q316$0.07$0.08$31.09 million$30.60 millionViewN/AView Earnings Details
9/8/2015Q216$0.08$0.08$29.81 million$30.50 millionViewN/AView Earnings Details
6/8/2015Q116$0.08$0.09$28.65 million$29.90 millionViewN/AView Earnings Details
3/24/2015Q415$0.02$0.04$23.50 million$24.90 millionViewN/AView Earnings Details
12/9/2014Q315$0.04$0.05$21.00 million$21.90 millionViewN/AView Earnings Details
9/9/2014Q2 15$0.05$0.07$20.32 million$20.89 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for HealthEquity (NASDAQ:HQY)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20171$0.10$0.10$0.10
(Data provided by Zacks Investment Research)


Dividend History for HealthEquity (NASDAQ:HQY)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading and Institutional Ownership History for HealthEquity (NASDAQ:HQY)
Insider Ownership Percentage: 19.00%
Institutional Ownership Percentage: 90.37%
Insider Trades by Quarter for HealthEquity (NASDAQ:HQY)
Institutional Ownership by Quarter for HealthEquity (NASDAQ:HQY)
Insider Trades by Quarter for HealthEquity (NASDAQ:HQY)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/17/2017Stephen NeelemanInsiderSell8,500$50.83$432,055.00View SEC Filing  
7/14/2017Berkley Capital, LlcMajor ShareholderSell72,791$51.41$3,742,185.31View SEC Filing  
7/14/2017Frank MediciDirectorSell537,102$51.24$27,521,106.48View SEC Filing  
7/13/2017Frank MediciDirectorSell131,800$51.42$6,777,156.00View SEC Filing  
7/12/2017Frank MediciDirectorSell332,511$51.13$17,001,287.43View SEC Filing  
7/7/2017Berkley Capital, LlcMajor ShareholderSell210,398$50.26$10,574,603.48View SEC Filing  
7/7/2017Frank MediciDirectorSell186,749$50.26$9,386,004.74View SEC Filing  
7/5/2017Frank MediciDirectorSell23,649$50.27$1,188,835.23View SEC Filing  
6/26/2017Berkley Capital, LlcMajor ShareholderSell56,067$51.79$2,903,709.93View SEC Filing  
6/23/2017Berkley Capital, LlcMajor ShareholderSell54,967$51.78$2,846,191.26View SEC Filing  
6/21/2017Berkley Capital, LlcMajor ShareholderSell129,263$51.95$6,715,212.85View SEC Filing  
6/21/2017Frank MediciDirectorSell154,265$51.94$8,012,524.10View SEC Filing  
6/20/2017Berkley Capital, LlcMajor ShareholderSell21,000$51.86$1,089,060.00View SEC Filing  
6/19/2017Berkley Capital, LlcMajor ShareholderSell4,002$51.99$208,063.98View SEC Filing  
6/15/2017Stephen NeelemanInsiderSell8,500$50.40$428,400.00View SEC Filing  
6/14/2017Frank MediciDirectorSell210,906$52.03$10,973,439.18View SEC Filing  
6/13/2017Berkley Capital, LlcMajor ShareholderSell248,351$52.80$13,112,932.80View SEC Filing  
6/5/2017Ashley DreierVPSell10,000$47.81$478,100.00View SEC Filing  
6/2/2017Stephen NeelemanInsiderSell40,000$48.36$1,934,400.00View SEC Filing  
5/1/2017Jon KesslerInsiderSell30,000$45.43$1,362,900.00View SEC Filing  
4/20/2017Darcy G MottVPSell10,000$43.44$434,400.00View SEC Filing  
4/17/2017Stephen NeelemanInsiderSell8,500$43.45$369,325.00View SEC Filing  
4/13/2017Delano LaddEVPSell1,095$43.60$47,742.00View SEC Filing  
4/4/2017Jon KesslerInsiderSell30,000$42.24$1,267,200.00View SEC Filing  
4/3/2017Jon KesslerCEOSell20,000$41.85$837,000.00View SEC Filing  
3/30/2017Adrian T. DillonDirectorBuy5,000$40.53$202,650.00View SEC Filing  
3/24/2017Jon SoldanVPSell6,250$41.95$262,187.50View SEC Filing  
3/22/2017Stephen NeelemanInsiderSell1,200$46.18$55,416.00View SEC Filing  
3/20/2017Ashley DreierVPSell5,000$45.80$229,000.00View SEC Filing  
3/20/2017Darcy G MottCFOSell10,000$45.92$459,200.00View SEC Filing  
3/20/2017Stephen NeelemanInsiderSell55,518$46.19$2,564,376.42View SEC Filing  
3/17/2017Stephen NeelemanVice ChairmanSell53,218$46.20$2,458,671.60View SEC Filing  
3/16/2017Stephen NeelemanInsiderSell40,169$45.96$1,846,167.24View SEC Filing  
2/28/2017Stephen NeelemanVice ChairmanSell1,600$44.02$70,432.00View SEC Filing  
2/27/2017Stephen NeelemanVice ChairmanSell215$44.00$9,460.00View SEC Filing  
2/21/2017Darcy G MottCFOSell10,000$42.60$426,000.00View SEC Filing  
1/20/2017Darcy G MottVPSell10,000$47.73$477,300.00View SEC Filing  
1/19/2017Frank MediciDirectorSell1,000,000$46.45$46,450,000.00View SEC Filing  
1/3/2017Frank CorvinoDirectorSell35,000$40.33$1,411,550.00View SEC Filing  
12/20/2016Darcy G MottVPSell10,000$40.12$401,200.00View SEC Filing  
12/20/2016Manu S RanaDirectorSell382,352$40.72$15,569,373.44View SEC Filing  
12/9/2016Darcy G MottVPSell30,000$40.88$1,226,400.00View SEC Filing  
11/28/2016Ashley DreierVPSell5,000$43.38$216,900.00View SEC Filing  
11/1/2016Matthew SydneyVPSell25,000$32.52$813,000.00View SEC Filing  
10/25/2016Frank MediciDirectorSell2,205,884$35.85$79,080,941.40View SEC Filing  
10/20/2016Darcy G MottVPSell10,000$35.37$353,700.00View SEC Filing  
10/13/2016Stephen NeelemanInsiderSell30,000$36.19$1,085,700.00View SEC Filing  
9/20/2016Darcy G MottCFOSell10,000$35.03$350,300.00View SEC Filing  
9/20/2016Jon KesslerCEOSell54,712$35.07$1,918,749.84View SEC Filing  
9/19/2016Jon KesslerCEOSell65,288$35.02$2,286,385.76View SEC Filing  
9/15/2016Jon KesslerInsiderSell20,000$33.46$669,200.00View SEC Filing  
9/13/2016Stephen NeelemanInsiderSell30,000$33.22$996,600.00View SEC Filing  
9/12/2016Jon KesslerInsiderSell120,117$33.10$3,975,872.70View SEC Filing  
9/12/2016Jon SoldanVPSell25,000$33.55$838,750.00View SEC Filing  
9/1/2016Ashley DreierVPSell10,000$32.28$322,800.00View SEC Filing  
8/31/2016Jon KesslerInsiderSell34,883$33.00$1,151,139.00View SEC Filing  
8/23/2016Stephen NeelemanInsiderSell9,898$30.28$299,711.44View SEC Filing  
8/22/2016Darcy G MottCFOSell10,000$29.13$291,300.00View SEC Filing  
8/18/2016Stephen NeelemanInsiderSell102$30.00$3,060.00View SEC Filing  
7/25/2016Jon KesslerInsiderSell10,000$29.62$296,200.00View SEC Filing  
7/20/2016Darcy G MottVPSell10,000$30.23$302,300.00View SEC Filing  
7/15/2016Ian SacksDirectorSell100,000$30.27$3,027,000.00View SEC Filing  
7/15/2016Jon KesslerCEOSell10,000$30.05$300,500.00View SEC Filing  
7/13/2016Stephen NeelemanVice ChairmanSell30,000$30.52$915,600.00View SEC Filing  
6/30/2016Stephen NeelemanVice ChairmanSell17,967$30.20$542,603.40View SEC Filing  
6/23/2016Jon KesslerCEOSell10,000$29.00$290,000.00View SEC Filing  
6/23/2016Michael O LeavittDirectorSell6,250$29.17$182,312.50View SEC Filing  
6/22/2016Michael O LeavittDirectorSell28,083$29.16$818,900.28View SEC Filing  
6/20/2016Darcy G MottCFOSell10,000$29.30$293,000.00View SEC Filing  
6/15/2016Jon KesslerCEOSell110,000$29.17$3,208,700.00View SEC Filing  
6/14/2016Jon KesslerCEOSell38,119$29.09$1,108,881.71View SEC Filing  
6/13/2016Jon KesslerCEOSell6,288$29.02$182,477.76View SEC Filing  
6/13/2016Stephen NeelemanVice ChairmanSell20,000$28.87$577,400.00View SEC Filing  
6/9/2016Manu S RanaDirectorSell500,000$28.30$14,150,000.00View SEC Filing  
6/8/2016Stephen NeelemanVice ChairmanSell2,033$30.12$61,233.96View SEC Filing  
5/26/2016Stephen NeelemanVice ChairmanSell19,900$25.03$498,097.00View SEC Filing  
5/25/2016Darcy G MottCFOSell10,000$25.00$250,000.00View SEC Filing  
5/13/2016Stephen NeelemanVice ChairmanSell100$25.00$2,500.00View SEC Filing  
5/11/2016Jon KesslerCEOSell52,000$25.21$1,310,920.00View SEC Filing  
4/20/2016Darcy G MottCFOSell10,000$25.52$255,200.00View SEC Filing  
4/11/2016Manu S RanaDirectorSell500,000$23.48$11,740,000.00View SEC Filing  
4/4/2016Jon KesslerCEOSell93,000$25.06$2,330,580.00View SEC Filing  
4/1/2016Darcy G MottCFOSell30,000$25.00$750,000.00View SEC Filing  
1/4/2016Stephen NeelemanVice ChairmanSell11,346$25.03$283,990.38View SEC Filing  
12/21/2015Darcy G. MottCFOSell10,000$25.70$257,000.00View SEC Filing  
12/2/2015Stephen NeelemanVice ChairmanSell37,500$32.75$1,228,125.00View SEC Filing  
12/1/2015Ashley DreierVPSell3,125$32.32$101,000.00View SEC Filing  
11/20/2015Darcy G. MottCFOSell10,000$33.64$336,400.00View SEC Filing  
11/11/2015Matthew SydneyVPSell35,000$35.00$1,225,000.00View SEC Filing  
10/28/2015Jon KesslerCEOSell20,000$32.00$640,000.00View SEC Filing  
10/20/2015Darcy G. MottCFOSell10,000$30.28$302,800.00View SEC Filing  
10/1/2015Jon KesslerCEOSell35,000$28.92$1,012,200.00View SEC Filing  
9/25/2015Frank MediciDirectorSell2,300,000$29.50$67,850,000.00View SEC Filing  
9/22/2015Frank MediciDirectorSell12,500$29.56$369,500.00View SEC Filing  
9/21/2015Darcy G. MottCFOSell10,000$30.50$305,000.00View SEC Filing  
9/17/2015Michael O LeavittDirectorSell93,703$29.82$2,794,223.46View SEC Filing  
9/16/2015Ian SacksDirectorSell50,000$29.74$1,487,000.00View SEC Filing  
9/15/2015Ian SacksDirectorSell50,000$29.99$1,499,500.00View SEC Filing  
9/14/2015Michael O LeavittDirectorSell41,297$30.57$1,262,449.29View SEC Filing  
9/11/2015Stephen NeelemanVice ChairmanSell50,000$30.06$1,503,000.00View SEC Filing  
9/3/2015Ashley DreierVPSell3,125$30.00$93,750.00View SEC Filing  
9/1/2015Jon KesslerCEOSell35,000$28.97$1,013,950.00View SEC Filing  
6/15/2015Ashley DreierVPSell3,125$28.50$89,062.50View SEC Filing  
5/11/2015Berkley Capital Investors, L.PMajor ShareholderSell2,250,000$24.86$55,935,000.00View SEC Filing  
5/11/2015Darcy G MottCFOSell120,000$24.86$2,983,200.00View SEC Filing  
5/11/2015Frank MediciDirectorSell1,125,000$24.86$27,967,500.00View SEC Filing  
5/11/2015Jon KesslerCEOSell100,000$24.86$2,486,000.00View SEC Filing  
4/28/2015Ashley DreierVPSell3,125$27.00$84,375.00View SEC Filing  
8/5/2014Darcy G MottCFOBuy2,000$14.00$28,000.00View SEC Filing  
8/5/2014Frank MediciDirectorBuy12,500$14.00$175,000.00View SEC Filing  
8/5/2014Frode JensenVPBuy3,000$14.00$42,000.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for HealthEquity (NASDAQ:HQY)
Latest Headlines for HealthEquity (NASDAQ:HQY)
DateHeadline logoHealthEquity, Inc. breached its 50 day moving average in a Bearish Manner : HQY-US : July 20, 2017 - July 20 at 11:06 PM logoZacks: Brokerages Expect Healthequity Inc (HQY) Will Announce Quarterly Sales of $55.74 Million - July 20 at 1:24 PM logoInsider Selling: HealthEquity, Inc. (HQY) Insider Sells 8,500 Shares of Stock - July 19 at 10:14 PM logo$0.14 EPS Expected for HealthEquity, Inc. (HQY) This Quarter - July 18 at 1:32 PM logoFinancial Review: Fluidigm Corporation (FLDM) versus HealthEquity (NASDAQ:HQY) - July 15 at 12:28 AM logoBerkley Capital, Llc Sells 72,791 Shares of HealthEquity, Inc. (HQY) Stock - July 14 at 10:56 PM logoFrank Medici Sells 131,800 Shares of HealthEquity, Inc. (NASDAQ:HQY) Stock - July 14 at 10:56 PM logoHealthEquity, Inc. (HQY) Director Sells $17,001,287.43 in Stock - July 14 at 10:56 PM logoFrank Medici Sells 537,102 Shares of HealthEquity, Inc. (HQY) Stock - July 14 at 10:56 PM logoWhy HealthEquity (HQY) Could Be an Impressive Growth Stock - Nasdaq - July 13 at 4:14 PM logoWhy HealthEquity (HQY) Could Be an Impressive Growth Stock - July 13 at 4:14 PM logoInsider Selling: HealthEquity, Inc. (HQY) Director Sells 23,649 Shares of Stock - July 7 at 10:43 PM logoHealthEquity, Inc. (HQY) Director Frank Medici Sells 186,749 Shares - July 7 at 10:43 PM logoBerkley Capital, Llc Sells 210,398 Shares of HealthEquity, Inc. (NASDAQ:HQY) Stock - July 7 at 10:42 PM logoHealthEquity, Inc. (HQY) Given Average Rating of "Buy" by Analysts - July 7 at 8:55 AM logoHealthEquity's CEO to Present at EBRI Policy Forum - GlobeNewswire (press release) - July 6 at 1:13 AM logoHealthEquity’s CEO to Present at EBRI Policy Forum - July 5 at 8:10 PM logoHealthEquity's (HQY) Overweight Rating Reaffirmed at Cantor Fitzgerald - July 5 at 10:30 AM logoHealthEquity, Inc (HQY) PT Raised to $56 at Cantor Fitzgerald, "Management Meetings Confirm Positive Growth Outlook" - July 5 at 8:03 AM logoETFs with exposure to HealthEquity, Inc. : July 4, 2017 - July 5 at 8:03 AM logoThis Health Savings Firm Could Skyrocket On TrumpCare - June 30 at 7:44 PM logoHealthEquity, Inc. (HQY) Major Shareholder Berkley Capital, Llc Sells 54,967 Shares - June 28 at 10:23 PM logoInsider Selling: HealthEquity, Inc. (HQY) Major Shareholder Sells 56,067 Shares of Stock - June 27 at 10:32 PM logoEarnings Highlights and Review: HealthEquity's Quarterly Revenue Jumped 26%; Net Income Rocketed 74% - June 26 at 7:29 PM logo$55.74 Million in Sales Expected for HealthEquity, Inc. (HQY) This Quarter - June 24 at 9:56 AM logoETFs with exposure to HealthEquity, Inc. : June 22, 2017 - June 22 at 8:13 PM logoA Stock Sinks Below Its Buy Point; When Should You Get Back In? - June 22 at 1:30 PM logo Analysts Expect HealthEquity, Inc. (HQY) to Announce $0.14 EPS - June 22 at 9:04 AM logoInsider Selling: HealthEquity, Inc. (HQY) Major Shareholder Sells 129,263 Shares of Stock - June 21 at 10:27 PM logoHealthEquity, Inc. (HQY) Major Shareholder Berkley Capital, Llc Sells 21,000 Shares - June 21 at 10:27 PM logoHealthEquity, Inc. (HQY) Major Shareholder Sells $208,063.98 in Stock - June 21 at 10:26 PM logoInsider Selling: HealthEquity, Inc. (HQY) Director Sells 154,265 Shares of Stock - June 21 at 7:22 PM logoHealthEquity, Inc. (HQY) Insider Stephen Neeleman Sells 8,500 Shares - June 19 at 7:34 PM logoFrank Medici Sells 210,906 Shares of HealthEquity, Inc. (HQY) Stock - June 16 at 10:16 PM logoEarnings Highlights and Review: Veeva's Quarterly Sales Jumped 32%; Earnings Rocket 188% - June 16 at 6:32 PM logoBerkley Capital, Llc Sells 248,351 Shares of HealthEquity, Inc. (HQY) Stock - June 13 at 10:32 PM logoETFs with exposure to HealthEquity, Inc. : June 12, 2017 - June 12 at 3:32 PM logoOppenheimer Holdings, Inc. Reaffirms "Outperform" Rating for HealthEquity, Inc. (HQY) - June 12 at 1:08 PM logoHealthEquity, Inc. (HQY) Receives Consensus Rating of "Buy" from Analysts - June 12 at 9:44 AM logoHealthequity Inc (HQY) President and CEO Jon Kessler Sold $7.5 million of Shares - Nasdaq - June 10 at 11:10 PM logoHealthEquity (HQY): Raising PT After Non Deal Roadshow - Oppenheimer - - June 10 at 4:12 AM logoHealthEquity, Inc. :HQY-US: Earnings Analysis: Q1, 2018 By the Numbers : June 9, 2017 - June 9 at 6:09 PM logoCommit To Purchase HealthEquity At $45, Earn 9% Annualized Using Options - Nasdaq - June 8 at 11:44 PM logoHealthEquity Reaches Analyst Target Price - Nasdaq - June 8 at 9:49 AM logoHealthequity Inc (HQY) VP Sells $478,100.00 in Stock - June 7 at 10:53 PM logoHealthEquity's (HQY) CEO Jon Kessler on Q1 2018 Results - Earnings Call Transcript - Seeking Alpha - June 7 at 5:18 PM logoCantor Fitzgerald Reiterates "Overweight" Rating for Healthequity Inc (HQY) - June 7 at 12:22 PM logoEdited Transcript of HQY earnings conference call or presentation 6-Jun-17 9:00pm GMT - June 7 at 10:29 AM logoHealthequity Inc (HQY) Issues Earnings Results, Beats Expectations By $0.03 EPS - June 7 at 8:02 AM logoHealthequity Inc (HQY) Price Target Increased to $57.00 by Analysts at Chardan Capital - June 7 at 7:34 AM



HealthEquity (HQY) Chart for Tuesday, July, 25, 2017

This page was last updated on 7/25/2017 by Staff